cysteamine has been researched along with Adult Fanconi Syndrome in 62 studies
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 6 (9.68) | 18.7374 |
1990's | 2 (3.23) | 18.2507 |
2000's | 12 (19.35) | 29.6817 |
2010's | 24 (38.71) | 24.3611 |
2020's | 18 (29.03) | 2.80 |
Authors | Studies |
---|---|
Cairns, D; Di Salvo, A; Kay, G; Knott, RM; Omran, Z | 1 |
Cairns, D; Hector, EE; Kay, G; Knott, RM; Omran, Z | 1 |
Benylles, A; Cairns, D; Kay, G; Knott, RM; Moloney, KA; Omran, Z | 1 |
Grebe, J; Grüneberg, M; Harms, E; Klank, S; Marquardt, T; Ottolenghi, C; Reunert, J; van Stein, C | 1 |
Abouelwoun, II; Atia, FM; Elkhateeb, N; Elmonem, MA; Helmy, R; Selim, R; Soliman, NA | 1 |
Acham-Roschitz, B; Arbeiter, K; Billing, H; Büscher, A; Haffner, D; Hagenberg, M; Hohenfellner, K; Jagodzinski, C; Kanzelmeyer, N; Kemper, MJ; Kluck, R; Müller, S; Oh, J; Pavičić, L; Thumfart, J; Tönshoff, B; Weber, LT; Zivicnjak, M | 1 |
Ariceta, G; Elenberg, E; Hohenfellner, K; Nesterova, G; Soliman, NA; Topaloglu, R | 1 |
Canalini, F; Cassiman, D; Emma, F; Goffredo, BM; Levtchenko, E; Montini, G; Pennesi, M; Peruzzi, L; Rossi, S; Verrina, E | 1 |
Acham-Roschitz, B; Arbeiter, K; Bald, M; Benz, M; Billing, H; Boulesteix, AL; Buescher, A; Gahl, WA; Galiano, M; Haffner, D; Hohenfellner, K; Hoppe, B; John-Kroegel, U; Kettwig, M; Klaus, G; Marx-Berger, D; Moeller, K; Moser, K; Mueller, D; Nießl, C; Oh, J; Palm, K; Patzer, L; Pohl, M; Schlingmann, P; Seitz, B; Tönshoff, B; Treikauskas, U; von Vigier, RO; Wühl, E; Wygoda, S; Zirngibl, M | 1 |
Gahl, WA; Haffner, D; Hohenfellner, K; Nießl, C; Oh, J; Okorn, C; Palm, K; Schlingmann, KP; Wygoda, S | 1 |
Beck, BB; Bieniaś, B; Grenda, R; Kieć-Wilk, B; Kowalczyk, M; Marquardt, T; Nosek, H; Rubik, J; Sikora, P; Surowiec, P; Szymczak, M; Zaniew, M | 1 |
Ariceta, G; Awan, A; Besouw, M; Bockenhauer, D; Haffner, D; Harms, E; Hohenfellner, K; Janssen, MCH; Kanzelmeyer, N; Levtchenko, E; Niaudet, P; Novo, R; Pape, L; Servais, A; Sikora, P; Topaloglu, R; van den Heuvel, B; Veys, K; Wühl, E; Zadora, W | 1 |
Aase, SA; Bjerre, A; Brackman, D; Forsberg, B; Gudmundsdottir, H; Radtke, M; Siva, C; Woldseth, B | 1 |
Langman, CB | 1 |
Azimpour, K; Carlot, S; Game, D; Lashilola, S; McCarthy, M; van der Voort, J; Xu, W | 1 |
Anglicheau, D; Antignac, C; Boddaert, N; Boisgontier, J; Funalot, B; Hummel, A; Legendre, C; Lemaitre, H; Pontoizeau, C; Saitovitch, A; Sberro-Soussan, R; Scemla, A; Servais, A; Snanoudj, R | 1 |
Kasimer, RN; Langman, CB | 1 |
Dixon, AM; Straatmann, C; Styres, C | 1 |
Topaloglu, R | 1 |
Acquaviva-Bourdain, C; Bacchetta, J; Bertholet-Thomas, A; Bodénan, E; Cochat, P; Deschênes, G; Gaillard, S; Kassai, B; Laudy, V; Lemoine, S; Mercier, C; Morin, D; Nony, P; Ranchin, B; Roche, L; Rouges, C; Subtil, F; Vianey-Saban, C; Zarrabian, S | 1 |
Antignac, C; Ariceta, G; Bertholet-Thomas, A; Bettini, C; Bockenhauer, D; Collin, S; Cornelissen, E; Deschênes, G; Devuyst, O; Emma, F; Greco, M; Haffner, D; Hoff, WV; Hohenfellner, K; Hulton, S; Janssen, M; Levtchenko, E; Niaudet, P; Novo, R; Oh, J; Ozaltin, F; Pape, L; Ravà, L; Servais, A; Topaloglu, R; Veys, K | 1 |
Hemels, M; Karabis, A; Medic, G; van der Weijden, M | 1 |
Higashi, S; Ito, S; Matsunoshita, N; Nozu, K; Otani, M; Tokuhiro, E | 1 |
Brand, E; Canaan-Kuehl, S; Kaufeld, J; Kurschat, C; Oh, J; Pape, L; Weber, LT | 1 |
Ariceta, G; Awan, A; Bacchetta, J; Bechtold, S; Bergmann, C; Cassidy, N; Deschenes, G; Elenberg, E; Gahl, WA; Greil, O; Haffner, D; Harms, E; Herzig, N; Hohenfellner, K; Hoppe, B; Koeppl, C; Levtchenko, E; Lewis, MA; Nesterova, G; Rauch, F; Santos, F; Schlingmann, KP; Servais, A; Soliman, NA; Steidle, G; Sweeney, C; Topaloglu, R; Treikauskas, U; Tsygin, A; V Vigier, R; Veys, K; Zustin, J | 1 |
Trauner, DA; Viltz, L | 1 |
Besouw, MT; Cornelissen, EA; De Paepe, A; Desmet, K; Emma, F; Greco, M; Janssen, MC; Levtchenko, EN; Lilien, MR; Malfait, F; Nobili, F; Schneider, J; Skovby, F; Symoens, S; van den Heuvel, LP | 1 |
Bernardini, I; Gahl, WA; Nesterova, G; Williams, C | 1 |
Besouw, MT; Casteels, I; Dyck, MV; Levtchenko, EN; Pinxten, AM; Veys, KR | 1 |
Bertholet-Thomas, A; Choukroun, G; Decramer, S; Goizet, C; Llanas, B; Novo, R; Servais, A | 1 |
Sankawa, J | 1 |
Berryhill, A; Bhamre, S; Chaudhuri, A; Concepcion, W; Grimm, PC | 1 |
Bultynck, G; De Smedt, H; Elmonem, MA; Ivanova, EA; Levtchenko, EN; Mekahli, D; Missiaen, L; Pastore, A; van den Heuvel, LP | 1 |
Barshop, BA; Deschênes, G; Emma, F; Goodyer, P; Langman, CB; Levtchenko, EN; Lipkin, G; Midgley, JP; Ottolenghi, C; Servais, A; Soliman, NA; Thoene, JG | 1 |
Bäumner, S; Weber, LT | 1 |
Bazaraa, H; El-Baroudy, R; Rizk, A; Soliman, NA; Younan, A | 1 |
Dimitriou, E; Emma, F; Karavitakis, EM; Kosma, K; Michelakakis, H; Xaidara, A | 1 |
Dakshinamurty, KV; Prasad, N; Ram, R; Reddy, PN; Swarnalatha, G | 1 |
Brugnara, M; Emma, F; Greco, M; Pastore, A; Taranta, A; Zaffanello, M | 1 |
Lund, AM; Oczachowska-Kulik, AE; Pedersen, EB; Skovby, F | 1 |
Antignac, C; Brodin-Sartorius, A; Charbit, M; Cochat, P; Guest, G; Legendre, C; Lesavre, P; Moyse, D; Niaudet, P; Ottolenghi, C; Servais, A; Tête, MJ | 1 |
Bouazza, N; Chadefaux-Vekemans, B; Deschenes, G; Niaudet, P; Ottolenghi, C; Ricquier, D; Tréluyer, JM; Urien, S | 1 |
Bagger, MJ; Cochat, P; Cornelissen, E; Deschênes, G; Gaillard, S; Greenbaum, LA; Grimm, P; Langman, CB; Matossian, D; Morin, D; Niaudet, P; Rioux, P; Sarwal, M | 1 |
Buchan, B; Cairns, D; Kay, G; Matthews, KH | 1 |
Cabrera, BL; Dohil, R | 1 |
Geelen, JM; Levtchenko, EN; Monnens, LA | 1 |
Blom, H; de Graaf-Hess, AC; Levtchenko, EN; Monnens, LA; van den Heuvel, LP; Wilmer, M | 1 |
Bernardini, I; Gahl, WA; Kleta, R; Krasnewich, D; Phornphutkul, C; Ueda, M; Varade, WS | 1 |
Gahl, WA; Kleta, R | 1 |
Levtchenko, E; Monnens, L | 1 |
Kleta, R | 1 |
Balog, JZ; Gahl, WA; Kleta, R | 1 |
Gahl, W; Nesterova, G | 1 |
Lemons, R; Thoene, JG | 1 |
Dionisi-Vici, C; Federici, G; Greco, M; Pastore, A; Ribes, A; Rizzo, C; Rizzoni, G | 1 |
Blom, HJ; de Graaf-Hess, A; Levtchenko, EN; Monnens, LA | 1 |
Case, L; De Vecchi, A; Edefonti, A; Gaboardi, F; Graziani, G | 1 |
Crocker, JF; DeWolfe, MS; Girardin, EP | 1 |
Bernardini, I; Charnas, L; Dalakas, MC; Gahl, WA; Ishak, KG; Markello, TC | 1 |
Bernar, J; Bernardini, I; Dalakas, M; Gahl, WA; Harper, GS; Hoeg, JM; Hurko, O; Rizzo, WB | 1 |
Blumberg, A; da Silva, VA; Lavanchy, P; Lüthy, CM; Oetliker, OH; Suter, H; Wyss, SR; Zurbrügg, RP | 1 |
Schneider, JA | 1 |
13 review(s) available for cysteamine and Adult Fanconi Syndrome
Article | Year |
---|---|
Newborn Screening: Review of its Impact for Cystinosis.
Topics: Adult; Cysteamine; Cystinosis; Fanconi Syndrome; Humans; Infant, Newborn; Neonatal Screening; Pilot Projects | 2022 |
Biomarkers in Nephropathic Cystinosis: Current and Future Perspectives.
Topics: Biomarkers; Cysteamine; Cystine; Cystinosis; Fanconi Syndrome; Humans; Quality of Life | 2022 |
Adult complications of nephropathic cystinosis: a systematic review.
Topics: Adult; Cysteamine; Cystinosis; Fanconi Syndrome; Humans; Kidney Failure, Chronic; Kidney Transplantation | 2021 |
Nephropathic cystinosis: an update on genetic conditioning.
Topics: Amino Acid Transport Systems, Neutral; Cysteamine; Cystine; Cystinosis; Fanconi Syndrome; Humans; Mutation | 2021 |
A systematic literature review of cysteamine bitartrate in the treatment of nephropathic cystinosis.
Topics: Cysteamine; Cystinosis; Fanconi Syndrome; Humans; Randomized Controlled Trials as Topic | 2017 |
[Cystinosis : Diagnosis, cystine-depleting therapy, and transition].
Topics: Adult; Child; Child, Preschool; Cysteamine; Cystine; Cystine Depleting Agents; Cystinosis; Fanconi Syndrome; Humans; Kidney; Lysosomes; Male; Quality of Life | 2018 |
Cystinosis: a new perspective.
Topics: Child; Child, Preschool; Cysteamine; Cystinosis; Fanconi Syndrome; Humans; Infant; Kidney Transplantation | 2016 |
[Cystinosis in adults: A systemic disease].
Topics: Adolescent; Adult; Cysteamine; Cystine Depleting Agents; Cystinosis; Fanconi Syndrome; Humans; Kidney Failure, Chronic; Kidney Transplantation; Renal Insufficiency | 2015 |
[Improved prognosis of cystinosis achieved by treatment with cysteamine and by kidney transplantation].
Topics: Cysteamine; Cystinosis; Fanconi Syndrome; Humans; Kidney Failure, Chronic; Kidney Transplantation; Prognosis; Treatment Outcome | 2011 |
[From gene to disease: cystinosis].
Topics: Amino Acid Transport Systems, Neutral; Cysteamine; Cystine; Cystinosis; Fanconi Syndrome; Gene Deletion; Glycoproteins; Humans; Membrane Proteins; Membrane Transport Proteins; Renal Insufficiency | 2004 |
Pharmacological treatment of nephropathic cystinosis with cysteamine.
Topics: Administration, Oral; Adolescent; Adult; Child; Child, Preschool; Cysteamine; Cystinosis; Fanconi Syndrome; Humans; Infant | 2004 |
Nephropathic cystinosis: late complications of a multisystemic disease.
Topics: Administration, Oral; Adolescent; Adult; Child; Cysteamine; Cystinosis; Disease Progression; Fanconi Syndrome; Genetic Predisposition to Disease; Humans; Kidney Failure, Chronic; Kidney Transplantation; Life Expectancy; Male; Middle Aged; Severity of Illness Index; Treatment Outcome | 2008 |
[Fanconi syndrome].
Topics: Acidosis; Adolescent; Bence Jones Protein; beta 2-Microglobulin; Child; Child, Preschool; Cysteamine; Dithiothreitol; Fanconi Syndrome; Glycosuria; Humans; Hypophosphatasia; Kidney; Kidney Transplantation; Male; Rickets | 1979 |
2 trial(s) available for cysteamine and Adult Fanconi Syndrome
Article | Year |
---|---|
Population pharmacokinetics and pharmacodynamics of cysteamine in nephropathic cystinosis patients.
Topics: Adolescent; Adult; Body Weight; Child; Child, Preschool; Cysteamine; Cystine; Cystinosis; Dose-Response Relationship, Drug; Fanconi Syndrome; Female; Humans; Infant; Male; Nephrotic Syndrome; Radiation-Protective Agents; Treatment Outcome; Young Adult | 2011 |
A randomized controlled crossover trial with delayed-release cysteamine bitartrate in nephropathic cystinosis: effectiveness on white blood cell cystine levels and comparison of safety.
Topics: Adolescent; Adult; Child; Cross-Over Studies; Cysteamine; Cystine; Cystinosis; Delayed-Action Preparations; Fanconi Syndrome; Female; Humans; Leukocytes; Male; Nephrotic Syndrome; Young Adult | 2012 |
47 other study(ies) available for cysteamine and Adult Fanconi Syndrome
Article | Year |
---|---|
PEGylated derivatives of cystamine as enhanced treatments for nephropathic cystinosis.
Topics: Cells, Cultured; Cystamine; Cystinosis; Fanconi Syndrome; Fibroblasts; Humans; Nephrotic Syndrome; Polyethylene Glycols; Prodrugs | 2011 |
Folate pro-drug of cystamine as an enhanced treatment for nephropathic cystinosis.
Topics: Administration, Oral; Cell Line; Cystamine; Cystinosis; Fanconi Syndrome; Humans; Nephrotic Syndrome; Prodrugs | 2011 |
Synthesis and in vitro evaluation of novel pro-drugs for the treatment of nephropathic cystinosis.
Topics: Cystamine; Cystinosis; Fanconi Syndrome; Fibroblasts; Glutarates; Humans; Nephrotic Syndrome; Prodrugs; Succinic Acid | 2011 |
A comparison of immediate release and delayed release cysteamine in 17 patients with nephropathic cystinosis.
Topics: Cysteamine; Cystine; Cystinosis; Fanconi Syndrome; Humans; Quality of Life; Retrospective Studies | 2021 |
Clinical and neurophysiological characterization of early neuromuscular involvement in children and adolescents with nephropathic cystinosis.
Topics: Adolescent; Child; Cohort Studies; Cysteamine; Cystinosis; Fanconi Syndrome; Female; Humans; Male; Muscular Diseases | 2022 |
Body growth, upper arm fat area, and clinical parameters in children with nephropathic cystinosis compared with other pediatric chronic kidney disease entities.
Topics: Adipose Tissue; Adolescent; Arm; Child; Child, Preschool; Cysteamine; Cystinosis; Fanconi Syndrome; Female; Growth Hormone; Humans; Male; Prospective Studies; Renal Insufficiency, Chronic | 2022 |
Relationship between age at initiation of cysteamine treatment, adherence with therapy, and glomerular kidney function in infantile nephropathic cystinosis.
Topics: Child; Cysteamine; Cystinosis; Fanconi Syndrome; Humans; Infant; Infant, Newborn; Kidney | 2022 |
Beneficial effects of starting oral cysteamine treatment in the first 2 months of life on glomerular and tubular kidney function in infantile nephropathic cystinosis.
Topics: Cysteamine; Cystine; Cystinosis; Fanconi Syndrome; Humans; Infant; Infant, Newborn; Kidney | 2022 |
Nephropathic cystinosis in Poland: a 40-year retrospective study.
Topics: Adult; Child; Cysteamine; Cystine; Cystinosis; Fanconi Syndrome; Humans; Kidney Failure, Chronic; Poland; Retrospective Studies; Young Adult | 2022 |
Outcome of infantile nephropathic cystinosis depends on early intervention, not genotype: A multicenter sibling cohort study.
Topics: Adolescent; Adult; Child; Child, Preschool; Cohort Studies; Cysteamine; Cystinosis; Fanconi Syndrome; Humans; Infant, Newborn; Kidney Failure, Chronic; Retrospective Studies; Siblings; Young Adult | 2023 |
The effects of transitioning from immediate release to extended release cysteamine therapy in Norwegian patients with nephropathic cystinosis: a retrospective study.
Topics: Adult; Child; Cysteamine; Cystine; Cystinosis; Fanconi Syndrome; Humans; Retrospective Studies | 2023 |
Long-term clinical benefits of delayed-release cysteamine bitartrate capsules in patients with nephropathic cystinosis (response to "A comparison of immediate release and delayed release cysteamine in 17 patients with nephropathic cystinosis").
Topics: Capsules; Cysteamine; Cystinosis; Fanconi Syndrome; Humans; Retrospective Studies | 2023 |
Impact of compliance to oral cysteamine treatment on the costs of Kidney failure in patients with nephropathic cystinosis in the United Kingdom.
Topics: Cysteamine; Cystine; Cystinosis; Fanconi Syndrome; Humans; Patient Compliance; Renal Dialysis; Renal Insufficiency; United Kingdom | 2023 |
Central nervous system complications in adult cystinosis patients.
Topics: Adolescent; Adult; Aged; Case-Control Studies; Central Nervous System Diseases; Cerebrovascular Circulation; Cysteamine; Cystine; Cystinosis; Fanconi Syndrome; Female; Gray Matter; Humans; Magnetic Resonance Imaging; Male; Middle Aged; Young Adult | 2020 |
An Infant With Vomiting, Constipation, and Weight Loss.
Topics: Calcitriol; Citric Acid; Constipation; Cysteamine; Cystinosis; Diagnosis, Differential; Fanconi Syndrome; Humans; Infant; Male; Phosphorus; Potassium; Sodium; Sodium Citrate; Vomiting; Weight Loss | 2020 |
Adherence to cysteamine in nephropathic cystinosis: A unique electronic monitoring experience for a better understanding. A prospective cohort study: CrYSTobs.
Topics: Adolescent; Adult; Child; Child, Preschool; Cysteamine; Cystinosis; Electronics; Fanconi Syndrome; Female; Humans; Male; Prospective Studies; Young Adult | 2021 |
An international cohort study spanning five decades assessed outcomes of nephropathic cystinosis.
Topics: Adult; Child, Preschool; Cohort Studies; Cysteamine; Cystine; Cystine Depleting Agents; Cystinosis; Fanconi Syndrome; Humans | 2021 |
Diagnostic challenge in a patient with nephropathic juvenile cystinosis: a case report.
Topics: Child; Cysteamine; Cystinosis; Fanconi Syndrome; Humans; Male; Nephrotic Syndrome; Slit Lamp Microscopy | 2017 |
Management of bone disease in cystinosis: Statement from an international conference.
Topics: Administration, Oral; Bone Diseases; Cysteamine; Cystinosis; Disease Management; Fanconi Syndrome; Female; Humans; Male | 2019 |
Effect of age at treatment on cognitive performance in patients with cystinosis.
Topics: Adolescent; Age Factors; Child; Child, Preschool; Cognition; Cognition Disorders; Cysteamine; Fanconi Syndrome; Humans; Young Adult | 2013 |
Copper deficiency in patients with cystinosis with cysteamine toxicity.
Topics: Adenosine Triphosphatases; Adolescent; Adult; Biomarkers; Cation Transport Proteins; Ceruloplasmin; Child; Child, Preschool; Collagen; Collagen Type I; Collagen Type I, alpha 1 Chain; Copper; Copper Transporter 1; Copper-Transporting ATPases; Cysteamine; Cystinosis; Fanconi Syndrome; Female; Genetic Markers; Humans; Male; Polymorphism, Genetic; Protective Agents; Protein-Lysine 6-Oxidase; Renal Agents; Sequence Analysis, DNA; Young Adult | 2013 |
Cystinosis: renal glomerular and renal tubular function in relation to compliance with cystine-depleting therapy.
Topics: Administration, Oral; Adolescent; Adult; Age Factors; Biomarkers; Child; Cysteamine; Cystine; Cystine Depleting Agents; Cystinosis; Fanconi Syndrome; Female; Humans; Kidney; Kidney Failure, Chronic; Kidney Function Tests; Leukocytes; Linear Models; Male; Maximum Tolerated Dose; Medication Adherence; Middle Aged; Retrospective Studies; Risk Factors; Time Factors; Treatment Outcome; Young Adult | 2015 |
[Quality of life improves].
Topics: Administration, Oral; Child; Child, Preschool; Cysteamine; Cystinosis; Delayed-Action Preparations; Fanconi Syndrome; Humans; Microspheres; Quality of Life | 2015 |
Cysteamine in renal transplantation: A report of two patients with nephropathic cystinosis and the successful re-initiation of cysteamine therapy during the immediate post-transplant period.
Topics: Adolescent; Child; Corneal Diseases; Cysteamine; Cystinosis; Drug Administration Schedule; Fanconi Syndrome; Female; Humans; Immunosuppression Therapy; Immunosuppressive Agents; Inpatients; Kidney Transplantation; Male; Postoperative Period; Renal Insufficiency; Tacrolimus; Treatment Outcome | 2016 |
Altered mTOR signalling in nephropathic cystinosis.
Topics: Amino Acid Transport Systems, Neutral; Autophagy; Cells, Cultured; Cysteamine; Cystinosis; Fanconi Syndrome; Humans; Kidney Failure, Chronic; Kidney Tubules, Proximal; Lysosomes; Mechanistic Target of Rapamycin Complex 1; Signal Transduction | 2016 |
Controversies and research agenda in nephropathic cystinosis: conclusions from a "Kidney Disease: Improving Global Outcomes" (KDIGO) Controversies Conference.
Topics: Adolescent; Adult; Age Factors; Amino Acid Transport Systems, Neutral; Child; Congresses as Topic; Cysteamine; Cystine; Cystine Depleting Agents; Cystinosis; Fanconi Syndrome; Genetic Testing; Genetic Therapy; Graft vs Host Disease; Hematopoietic Stem Cell Transplantation; Humans; Immunosuppression Therapy; Infant; Kidney Failure, Chronic; Kidney Transplantation; Lysosomes; Mutation; Rare Diseases; Renal Dialysis | 2016 |
Conversion from immediate- to extended-release cysteamine may decrease disease control and increase additional side effects.
Topics: Cysteamine; Cystinosis; Fanconi Syndrome; Humans; Retrospective Studies | 2017 |
Nephropathic cystinosis in children: An overlooked disease.
Topics: Administration, Oral; Administration, Topical; Child; Child, Preschool; Cornea; Corneal Diseases; Cysteamine; Cystinosis; Diagnostic Techniques, Ophthalmological; Disease Progression; Fanconi Syndrome; Female; Humans; Infant; Kidney Failure, Chronic; Male; Medication Adherence; Ophthalmic Solutions; Predictive Value of Tests; Severity of Illness Index; Treatment Outcome | 2009 |
Chitotriosidase plasma activity in nephropathic cystinosis.
Topics: Child, Preschool; Cysteamine; Cystinosis; Fanconi Syndrome; Hexosaminidases; Humans; Nephrotic Syndrome | 2009 |
Quiz page. Fanconi syndrome caused by cystinosis, intermediate type.
Topics: Adult; Cysteamine; Cystine; Cystinosis; Diagnosis, Differential; Fanconi Syndrome; Humans; Male; Nephritis, Interstitial; Radiation-Protective Agents; Sjogren's Syndrome | 2009 |
Long-term outcome of nephropathic cystinosis: a 20-year single-center experience.
Topics: Adolescent; Angiotensin-Converting Enzyme Inhibitors; Child; Child, Preschool; Cysteamine; Cystinosis; Disease Progression; Drug Therapy, Combination; Early Diagnosis; Fanconi Syndrome; Female; Humans; Infant; Italy; Kaplan-Meier Estimate; Kidney; Kidney Failure, Chronic; Logistic Models; Male; Nephrotic Syndrome; Retrospective Studies; Risk Assessment; Risk Factors; Time Factors; Treatment Outcome | 2010 |
Cysteamine therapy delays the progression of nephropathic cystinosis in late adolescents and adults.
Topics: Adolescent; Adult; Age Factors; Amino Acid Transport Systems, Neutral; Child; Child, Preschool; Cysteamine; Cystinosis; Diabetes Complications; Disease Progression; Educational Status; Employment; Fanconi Syndrome; Female; Follow-Up Studies; Humans; Hypothyroidism; Infant; Kaplan-Meier Estimate; Kidney Failure, Chronic; Male; Middle Aged; Nephrotic Syndrome; Nervous System Diseases; Neuromuscular Diseases; Radiation-Protective Agents; Young Adult | 2012 |
Suppository formulations as a potential treatment for nephropathic cystinosis.
Topics: Chemistry, Pharmaceutical; Cysteamine; Cystine; Cystinosis; Drug Stability; Excipients; Fanconi Syndrome; Nephrotic Syndrome; Polyethylene Glycols; Solubility; Suppositories | 2012 |
Treatment of cystinosis with delayed-release cysteamine: 6-year follow-up.
Topics: Adolescent; Biomarkers; Chemistry, Pharmaceutical; Creatinine; Cysteamine; Cystinosis; Delayed-Action Preparations; Drug Administration Schedule; Fanconi Syndrome; Female; Glomerular Filtration Rate; Humans; Kidney; Leukocyte Count; Male; Nephrotic Syndrome; Time Factors; Treatment Outcome; Young Adult | 2013 |
Follow-up and treatment of adults with cystinosis in the Netherlands.
Topics: Adult; Central Nervous System Diseases; Cysteamine; Cystinosis; Endocrine System Diseases; Fanconi Syndrome; Female; Follow-Up Studies; Humans; Kidney Transplantation; Male; Muscular Diseases; Netherlands; Postoperative Complications; Retrospective Studies; Socioeconomic Factors; Vision Disorders; Visual Acuity | 2002 |
Long-term follow-up of well-treated nephropathic cystinosis patients.
Topics: Cysteamine; Cystine; Fanconi Syndrome; Female; Follow-Up Studies; Glomerular Filtration Rate; Growth Disorders; Humans; Infant; Infant, Newborn; Male; Time Factors; Treatment Outcome | 2004 |
Development of Fanconi syndrome during infancy in a patient with cystinosis.
Topics: Cysteamine; Cystinosis; Fanconi Syndrome; Humans; Infant; Male; Renal Agents | 2006 |
A deeper look into cysteamine absorption for the treatment of cystinosis.
Topics: Cysteamine; Cystinosis; Fanconi Syndrome; Gastrins; Humans; Intestine, Small | 2006 |
Nephropathic cystinosis in adults: natural history and effects of oral cysteamine therapy.
Topics: Administration, Oral; Adolescent; Adult; Amino Acid Transport Systems, Neutral; Cysteamine; Cystinosis; Fanconi Syndrome; Female; Gene Deletion; Humans; Kidney Transplantation; Kidney Tubules; Male; Middle Aged; Retrospective Studies | 2007 |
Cystine depletion of cystinotic tissues by phosphocysteamine (WR638).
Topics: Child; Cystaphos; Cysteamine; Cystine; Cystinosis; Fanconi Syndrome; Fibroblasts; Humans; Male; Organothiophosphorus Compounds | 1980 |
Pyroglutamic aciduria and nephropathic cystinosis.
Topics: 3-Hydroxybutyric Acid; Case-Control Studies; Child, Preschool; Cysteamine; Cystinosis; Fanconi Syndrome; Humans; Infant; Ketoglutaric Acids; Lactates; Malates; Pyrrolidonecarboxylic Acid; Succinates | 1999 |
Negligible urinary cysteamine loss in cystinosis patients with Fanconi syndrome.
Topics: Adolescent; Child; Cysteamine; Cystinosis; Fanconi Syndrome; Humans | 2002 |
Treatment of cystinosis with cysteamine.
Topics: Cysteamine; Cystinosis; Fanconi Syndrome; Humans; Infant; Male | 1979 |
Parenchymal organ cystine depletion with long-term cysteamine therapy.
Topics: Adolescent; Child; Cysteamine; Cystine; Cystinosis; Fanconi Syndrome; Humans; Infant; Kidney; Kidney Diseases; Liver; Lung; Male; Microscopy, Electron, Scanning; Muscles; Pancreas; Spleen | 1992 |
Oral carnitine therapy in children with cystinosis and renal Fanconi syndrome.
Topics: Administration, Oral; Biological Transport; Carnitine; Cells, Cultured; Child; Child, Preschool; Cholesterol; Cysteamine; Cystinosis; Fanconi Syndrome; Fatty Acids, Nonesterified; Humans; Infant; Kidney Transplantation; Lipid Metabolism; Metabolic Clearance Rate; Muscles; Oculocerebrorenal Syndrome; Renal Tubular Transport, Inborn Errors; Triglycerides | 1988 |
Long-term treatment of infantile nephropathic cystinosis with cysteamine.
Topics: Bone Marrow; Child; Child, Preschool; Cysteamine; Cystine; Cystinosis; Fanconi Syndrome; Growth; Humans; Infant; Infant, Newborn; Kidney Failure, Chronic; Leukocytes; Male | 1985 |
Therapy of cystinosis.
Topics: Cysteamine; Cystinosis; Fanconi Syndrome; Humans; Infant | 1985 |